SCHEDULE 13G/A: BlackRock Discloses 2.9% Passive Stake in Corbus Pharmaceuticals
Beneficial Ownership Disclosure
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 2.9% beneficial ownership stake in Corbus Pharmaceuticals Holdings Inc. as of June 30, 2025.
Summary
- BlackRock, Inc. beneficially owns 352,409 shares of Corbus Pharmaceuticals Holdings Inc. common stock.
- This ownership represents 2.9% of the class of securities.
- BlackRock holds sole voting power over 349,203 shares.
- BlackRock holds sole dispositive power over 352,409 shares.
- The filing indicates that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing (Schedule 13G) disclosing a passive ownership stake. It does not contain information that would inherently indicate positive or negative sentiment regarding the issuer's performance or outlook.
Future Outlook
NA
Industry Context
A Schedule 13G filing indicates a passive investment by a large institutional investor, such as BlackRock, in a public company. This type of filing is used when an investor holds less than 20% of a company's outstanding shares and does not intend to influence or control the company's management or policies. It is a routine disclosure for major asset managers, providing transparency on significant ownership stakes within the market.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional ownership stake in Corbus Pharmaceuticals Holdings Inc.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement |
| 07/16/2025 | Signature date of the Schedule 13G Amendment No. 1 |
Keywords
BlackRock, Corbus Pharmaceuticals Holdings Inc., Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.